BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11801595)

  • 1. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein.
    Sun XM; Bratton SB; Butterworth M; MacFarlane M; Cohen GM
    J Biol Chem; 2002 Mar; 277(13):11345-51. PubMed ID: 11801595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream regulatory role for XIAP in receptor-mediated apoptosis.
    Wilkinson JC; Cepero E; Boise LH; Duckett CS
    Mol Cell Biol; 2004 Aug; 24(16):7003-14. PubMed ID: 15282301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalostatin 1 selectively triggers the release of Smac/DIABLO and subsequent apoptosis that is characterized by an increased density of the mitochondrial matrix.
    Dirsch VM; Müller IM; Eichhorst ST; Pettit GR; Kamano Y; Inoue M; Xu JP; Ichihara Y; Wanner G; Vollmar AM
    Cancer Res; 2003 Dec; 63(24):8869-76. PubMed ID: 14695204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
    Srinivasula SM; Datta P; Fan XJ; Fernandes-Alnemri T; Huang Z; Alnemri ES
    J Biol Chem; 2000 Nov; 275(46):36152-7. PubMed ID: 10950947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
    Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
    Ng CP; Bonavida B
    Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
    Adrain C; Creagh EM; Martin SJ
    EMBO J; 2001 Dec; 20(23):6627-36. PubMed ID: 11726499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation.
    Hamacher-Brady A; Brady NR
    J Biol Chem; 2015 Sep; 290(36):22005-18. PubMed ID: 26134559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
    Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro.
    MacFarlane M; Merrison W; Bratton SB; Cohen GM
    J Biol Chem; 2002 Sep; 277(39):36611-6. PubMed ID: 12121969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.
    Deng Y; Lin Y; Wu X
    Genes Dev; 2002 Jan; 16(1):33-45. PubMed ID: 11782443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis.
    Bratton SB; Lewis J; Butterworth M; Duckett CS; Cohen GM
    Cell Death Differ; 2002 Sep; 9(9):881-92. PubMed ID: 12181739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation.
    Maas C; Verbrugge I; de Vries E; Savich G; van de Kooij LW; Tait SW; Borst J
    Cell Death Differ; 2010 Oct; 17(10):1613-23. PubMed ID: 20395960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-9 activation by the apoptosome is not required for fas-mediated apoptosis in type II Jurkat cells.
    Shawgo ME; Shelton SN; Robertson JD
    J Biol Chem; 2009 Nov; 284(48):33447-55. PubMed ID: 19758996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels.
    Kominsky DJ; Bickel RJ; Tyler KL
    J Virol; 2002 Nov; 76(22):11414-24. PubMed ID: 12388702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
    Pardo OE; Lesay A; Arcaro A; Lopes R; Ng BL; Warne PH; McNeish IA; Tetley TD; Lemoine NR; Mehmet H; Seckl MJ; Downward J
    Mol Cell Biol; 2003 Nov; 23(21):7600-10. PubMed ID: 14560006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSAP induces a unique Apaf-1 and Smac-dependent mitochondrial apoptotic pathway independent of Bcl-2 family proteins.
    Li T; Zeng L; Gao W; Cui MZ; Fu X; Xu X
    Biochim Biophys Acta; 2013 Mar; 1832(3):453-74. PubMed ID: 23207240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.
    Ferrer I; Planas AM
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):329-39. PubMed ID: 12722825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
    Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
    Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.